Your session is about to expire
← Back to Search
Tomosynthesis vs. Contrast-Enhanced Mammography for Breast Cancer (TOCEM Trial)
TOCEM Trial Summary
This trial will compare cancer detection rates of two types of mammograms, one with and one without contrast enhancement.
TOCEM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TOCEM Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a woman aged 30-85 with a history of breast cancer and have had a mammogram after treatment.I have had a reaction to iodine-based contrast before.I am a woman with kidney issues or my kidney function is low.I have had both of my breasts surgically removed.I am a woman currently undergoing chemotherapy for cancer.I have a lump or other symptoms in my breast.You have a previous abnormal result on a breast imaging test that needs further monitoring.I have implants in my breasts.
- Group 1: Contrast-enhanced mammogram
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the estimated enrollment rate for this experiment?
"Affirmative. According to the info on clinicaltrials.gov, this study is still seeking participants which it initially posted for in October 2019 and more recently updated in September 2022. The trial requires 1650 people from 3 different locations to take part."
May I qualify to take part in this medical trial?
"In order to be eligible, individuals must have a diagnosis of breast cancer and be aged between 30 and 85. This trial aims to recruit approximately 1650 participants."
Are there any opportunities still available for participation in this experiment?
"That is correct. Clinicaltrials.gov attests that this investigation, which was first advertised on October 23rd 2019, is actively recruiting participants. 1,650 individuals are needed from three distinct clinical locations to take part in the trial."
Does this research endeavor offer opportunities for individuals aged 45 and above?
"This particular clinical research effort is searching for participants between the ages of 30 and 85. Those younger than that age threshold can look to 370 alternative trials, while those older have access to 4,568 studies."
Share this study with friends
Copy Link
Messenger